| Methotrexate-based bilateral uterine arterial chemoembolization for treatment of cesarean scar pregnancy. | |
| | |
MedLine Citation:
|
PMID: 20726832 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We have evaluated the efficacy of methotrexate-based bilateral uterine arterial chemoembolization for treating cesarean scar pregnancy (CSP) in 52 women between January 2005 and December 2009. Ten patients experienced massive vaginal hemorrhage after a misdiagnosis and subsequent curettage. Bleeding in these patients was reduced after chemoembolization. Dilation and curettage was not done in five of these patients because ultrasound scanning showed sparse or no blood flow in the previous gestational sac area. The five remaining patients, along with additional 42 patients who were diagnosed with CSP, underwent ultrasound-guided dilation and curettage within 24-48 hours following chemoembolization. Patients tolerated the procedure well and only mild bleeding occurred. The positive clinical outcomes in these patients support the use of bilateral uterine artery chemoembolization for the treatment of CSP. |
| | |
Authors:
|
Fengbing Liang; Jing He |
Publication Detail:
|
Type: Journal Article Date: 2010-08-23 |
Journal Detail:
|
Title: Acta obstetricia et gynecologica Scandinavica Volume: 89 ISSN: 1600-0412 ISO Abbreviation: Acta Obstet Gynecol Scand Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-18 Completed Date: 2010-12-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370343 Medline TA: Acta Obstet Gynecol Scand Country: England |
Other Details:
|
Languages: eng Pagination: 1592-4 Citation Subset: IM |
Affiliation:
|
Obstetrics Department, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, People's Republic of China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cesarean Section / adverse effects*, methods Cicatrix / etiology, therapy* Cohort Studies Dilatation and Curettage Embolization, Therapeutic / methods* Female Follow-Up Studies Gestational Age Humans Methotrexate / administration & dosage* Pregnancy Pregnancy, Ectopic / prevention & control Retrospective Studies Risk Assessment Treatment Outcome Uterine Artery / drug effects* Uterine Rupture / prevention & control |
| Chemical | |
Reg. No./Substance:
|
59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Medical students learning the pelvic examination: evaluation of a clinical patient model.
Next Document: Targeting phosphoprotein profiling by combination of hydroxyapatite-based phosphoprotein enrichment ...